Rwanda
East African landlocked nation reporting Mpox clade Ib transmission.
Rwanda backs the M23, and Ebola reached its ally's ground when Bundibugyo crossed into M23-held South Kivu on 21 May 2026; that month Rwanda also reported community transmission of clade Ib mpox.
Last refreshed: 4 October 2026 · Appears in 1 active topic
Timeline for Rwanda
Mentioned in: Ebola shifts south to DR Congo's Butembo
Pandemics and BiosecurityMentioned in: Ebola crosses into M23-held South Kivu
Pandemics and BiosecurityBackground
Rwanda is a mountainous, landlocked country in East Africa of about 13 million people. Kigali, the capital, lies near the centre of the country. It borders Uganda, Burundi, Tanzania and DR Congo.
Its outbreak risk runs across those borders. In May 2026 Rwanda was among the countries reporting community transmission of clade Ib mpox, a lineage first identified in eastern DR Congo in 2023. Across its western border, the M23 armed group, which Rwanda backs, has governed South Kivu since February 2025. When Bundibugyo Ebola reached South Kivu on 21 May 2026, the territory had no outbreak-management system and no prior Ebola experience, and residents burned a treatment facility as the response team arrived.
The Congolese epidemic has since moved further into the east. By 23 September 2026 WHO counted 7,890 confirmed cases in DR Congo, and North Kivu supplied nearly 40% of new ones. For Rwanda the weight of that outbreak sits on its frontier with DR Congo.
Ebola reached M23-held South Kivu
Rwanda backs the M23 armed group, which has held South Kivu since February 2025. On 21 May 2026 the province confirmed its first Bundibugyo Ebola case, a 28-year-old WHO died before diagnosis, and residents torched a treatment facility as the response team arrived.
Under M23 rule South Kivu had no outbreak-management system in May 2026, which left Kigali's ally holding an Ebola front with no means to run it. By 23 September WHO counted 7,890 confirmed cases in DR Congo, and North Kivu, which also borders Rwanda, supplied nearly 40% of new ones.